ORUKA THERAPEUTICS INC (ORKA:NASDAQ)
$58.53 0.55 (0.9486%)
Analysed ORUKA THERAPEUTICS INC (ORKA:NASDAQ) News Sources
Leerink Partners Lifts PT on Oruka Therapeutics, Inc. (ORKA)
10-05-2026
yahoo.com
H.C. Wainwright Bullish on Halozyme Therapeutics, Inc. (HALO) Commercial Revenue Outlook
11-05-2026
yahoo.com
A Tiny Biotech Just Beat AbbVie's $17 Billion Drug. Should Investors Be Worried?
11-05-2026
fool.com
Halozyme Q1 Beat Driven by Royalty Outperformance, Strong Demand, Morgan Stanley
12-05-2026
yahoo.com
Oruka Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
13-05-2026
yahoo.com
Why This Biotech Fund Increased Its Oruka Therapeutics Stake Amid a Staggering 500% Rally
13-05-2026
fool.com
Why This Biotech Fund Opened a $9 Million Position in a Newly Public Cancer Company
13-05-2026
fool.com
Why This Biotech Fund Added $7 Million to an Oncology Stock Up 120%
13-05-2026
fool.com
Oruka Therapeutics (ORKA) Valuation Check After Psoriasis Trial Progress Partnerships And Fresh Funding
15-05-2026
yahoo.com
Oruka Therapeutics to Present at the 2026 Jefferies Global Healthcare Conference
28-05-2026
yahoo.com
What is the current price of ORUKA THERAPEUTICS INC (ORKA:NASDAQ)?
The current price of ORUKA THERAPEUTICS INC (ORKA:NASDAQ) is $58.53.
ORUKA THERAPEUTICS INC (ORKA:NASDAQ) absolute price change since previous trading day?
The absolute price change of ORUKA THERAPEUTICS INC (ORKA:NASDAQ) since the previous trading day is $0.55.
ORUKA THERAPEUTICS INC (ORKA:NASDAQ) percentage price change since previous trading day?
The percentage price change of ORUKA THERAPEUTICS INC (ORKA:NASDAQ) since the previous trading day is 0.9486%.
What is the most recent average sentiment score for ORUKA THERAPEUTICS INC (ORKA:NASDAQ)?
The most recent average sentiment score for ORUKA THERAPEUTICS INC (ORKA:NASDAQ) is 84 out of 100.
What is the most recent average sentiment for ORUKA THERAPEUTICS INC (ORKA:NASDAQ)?
The most recent sentiment for ORUKA THERAPEUTICS INC (ORKA:NASDAQ) is .
SEC-8K** Filing Available For ORUKA THERAPEUTICS INC (ORKA:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.